• Prior to the general development of B-mode ultrasound in the early 1980s, the only population-based approaches to evaluation of the pathogenesis, prevalence, and prognosis of atherosclerosis involved autopsy or investigation of symptomatic individuals undergoing coronary or peripheral angiography for stenotic disease.
• Prior to the general development of B-mode ultrasound in the early 1980s, the only population-based approaches to evaluation of the pathogenesis, prevalence, and prognosis of atherosclerosis involved autopsy or investigation of symptomatic individuals undergoing coronary or peripheral angiography for stenotic disease.
• The strong relation of carotid atherosclerosis to both risk factors and clinical outcome has prompted consideration of this as a link to cardiovascular disease.
• The extent of atherosclerosis can be quantifi ed with individual wall thicknesses or composite measures based on measurements across multiple sites.
• With implementation of quality control measures, the quantifi cation of intimal-medial thicknesses (IMTs) in the carotid system is highly reproducible.
• B-mode imaging of the artery wall correlated best with the combined intimal-medial-adventitial thickness as measured from histologic sections.
• A normal thickness may be represented by the median values of participants in their mid-40s (i.e., in the common carotid artery-0.60 mm for men and 0.54 mm for women).
• Since IMT is an index of chronic stable disease, associations with risk factors represent lifetime exposure. • Other population-based studies generally agree that traditional risk factors for cardiovascular events are related to IMT progression and that progression in healthy individuals is approximately 10 μm/year.
• The Food and Drug Administration (FDA) has long accepted effects of pharmacologic intervention on rate of progression of coronary stenosis as a marker for demonstration of clinical benefi t. More recently, the agency has similarly accepted change in progression of IMT measured by B-mode ultrasound.
• Extracranial carotid atherosclerosis has been independently associated with prevalent coronary artery and cerebrovascular disease.
• Increased IMT as identifi ed by B-mode ultrasound of the extracranial carotid arteries is also a predictor of incident coronary events and stroke or the combined end point as well as incident white matter lesions.
• Increased IMT of the common carotid is associated with increased rather than decreased lumen diameter.
• Use of IMT to evaluate the infl uence of heredity and/ or genetic variables on atherosclerosis is appealing. The noninvasive nature of this technology makes it ideal for use in large asymptomatic populations, while its reliability and its validity both as a faithful representation of underlying tissue and as a marker for increased vascular risk provide an opportunity to test associations.
• Use of this technology has provided hitherto unimagined new insights about risk factors for arterial disease and relations of asymptomatic arterial disease to symptom- c h a p t e r 8 3 atic illness, as well as relations of underlying atherosclerosis to incident coronary heart disease and stroke.
• The potential for B-mode ultrasound to identify individuals who will benefi t most from lifestyle modifi cation or pharmacologic intervention has not yet been fully realized.
• The stability of IMT makes it an ideal marker for response of the arterial wall to long-term risk factor exposure.
Background
Use of noninvasive methods for quantifi cation of atherosclerosis (the earliest of which was B-mode ultrasound) has led to a paradigm shift in the population-based investigation of arterial disease. Prior to the general development of B-mode ultrasound in the early 1980s, the only population-based approaches to evaluation of the pathogenesis, prevalence, and prognosis of atherosclerosis involved autopsy or investigation of symptomatic individuals undergoing coronary or peripheral angiography for stenotic disease. Angiography has long been used with great benefi t to identify symptomatic patients at high or low risk of developing clinical events (see Chapter 34) , but the risk of the technology precludes its broad use in asymptomatic healthy populations and/or those with minimal symptomatology. Over 15 years ago, Doppler ultrasound was used to show that asymptomatic individuals with extracranial carotid artery stenosis (>75%) had 5.5-fold increased risk of incident stroke and threefold increased risk of coronary disease compared to those with <50% stenosis. 1 However, the Doppler method identifi es only signifi cant blood fl ow abnormalities resulting from lumen stenosis and is insensitive to nonstenotic disease. Since it is now recognized that stenosis is only the "tip of the iceberg" of atherosclerosis, 2 a method that directly provides information on arterial walls rather than lumina is desirable in order to quantify the impact of risk factors on subclinical disease and on arterial remodeling as well as to identify disease before the occurrence of clinical events, and thus permit risk factor intervention early in selected high-risk individuals. In addition, individuals might be more likely to comply with treatment if they knew they had early disease. Identifi cation of subclinical atherosclerosis also enables investigators to distinguish between risk factors for underlying atherosclerosis and those for development of symptoms in individuals with atherosclerosis.
Subsequent to development of B-mode ultrasound, several other noninvasive or minimally invasive methods were developed for imaging structural components of vascular disease, including computed tomographic (CT) quantifi cation of coronary artery calcium, 3 magnetic resonance imaging of carotid and aortic disease, 4 and CT angiography.
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As yet there is no generally accepted noninvasive method for quantifying atherosclerosis of the coronary arteries, and, since atherosclerosis is a generalized disease, investigators have used surface B-mode ultrasound to quantify atherosclerosis of the extracranial carotid arteries. As a means of imaging chronic stable atherosclerotic vascular disease, Bmode ultrasound has many advantages, and has been related to traditional as well as new risk factors. [6] [7] [8] [9] [10] [11] [12] [13] Investigators have also defi ned rates of progression of extracranial carotid atherosclerosis [14] [15] [16] [17] [18] [19] [20] and effects of interventions (e.g., on lipids, diabetes, blood pressure) on progression rates. 21 It is clear that atherosclerosis of the extracranial arteries is associated with prevalent coronary artery [22] [23] [24] and cerebrovascular 24, 25 disease as well as incident coronary artery disease, 14, [26] [27] [28] [29] stroke, 26, 28, 30, 31 and all-cause mortality. 32 The strong relation of carotid atherosclerosis to risk factors on the one hand and to clinical outcome on the other has prompted consideration of this as a link to cardiovascular disease. More recently, investigators have quantifi ed the heritability of and genetic polymorphisms associated with carotid atherosclerosis. [33] [34] [35] This chapter summarizes new information with respect to the B-mode ultrasound methodology currently in use, its reliability and validity, its relationships with traditional and nontraditional risk factors for coronary artery disease, the association of risk factors with the progression of atherosclerosis, and the effects of interventions to modify progression. This chapter also reviews the association of extracranial carotid atherosclerosis with prevalent as well as incident coronary artery and cerebrovascular disease. Finally, this chapter summarizes the growing literature that identifi es the heritability of and genetic associations with carotid atherosclerosis.
Principles
Ultrasound B-mode imaging is based on the pulse-echo principle used in sonar, from which measurements of the arrival times of echoes from a source of pulsed ultrasound are used to create a two-dimensional real-time display of the echoproducing structures. The positions of the structures relative to the source are computed using the arrival times and an assumed value for the speed of propagation of the ultrasound energy between the source and structures. The ultrasound instrumentation required for the noninvasive assessment of atherosclerosis in superfi cial vessels uses short (two to three cycle) pulses of approximately 10 MHz ultrasound. This provides an axial resolution of approximately 0.1 to 0.2 mm. The distance between structures (e.g., arterial adventitia and lumen) initially separated by more than this resolution distance can be reliably measured, and changes in this distance over time can be ascertained with considerably greater precision, as determined by the changes in arrival times of the corresponding echoes.
The extent of atherosclerosis can be quantifi ed with individual wall thicknesses or composite measures based on measurements across multiple sites (e.g., the near and far walls of the internal carotid, bifurcation, and common carotid from the right and left sides). These composite measures may be raw sums or averages or may be estimates of these parameters from multivariate statistical methods. Individual measurements, such as those from the far wall of the common carotid, may be easiest to acquire. Composite measures may more broadly represent the total disease burden. Because they involve more information, if composite measures are estimated using appropriate multivariate methods, they are expected to provide the greatest statistical power and effi ciency, and are recommended as primary outcome measures for most clinical research studies. 21, 36, 37 Such approaches also are necessary to minimize biases associated with occasionally nonvisualized sites.
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Reproducibility
Although early B-mode studies focused on cross-sectional differences between populations, more recent investigation has turned to more demanding evaluations of progression and effects of interventions to retard progression. These studies mandate highly standardized protocols that include the defi nition of an anatomic landmark, identifi cation of an initial interrogation plane defi ned relative to the patient's anatomy, and careful circumferential scanning of the segment to identify the maximum wall thickness. Figure  83 .1 is a simplifi ed diagram of the carotid artery, which defi nes the segments of arterial walls examined with B-mode ultrasound in a recent international clinical trial, the Osteoporosis Prevention and Arterial Effects of Tibolone (OPAL) trial. 39 This diagram shows the artery as imaged from the initial interrogation plane (in which the internal and external carotids divide) and shows the anatomic landmark (tip of fl ow divider) relative to the segments that are defi ned. The 12 segments of interest are defi ned above. Different segments of the extracranial arteries have different potential for B-mode imaging. In OPAL, as in many other such trials, intimal-medial thickness (IMT) data were available in >99.5% of the screening and randomization visits on all segments except the right bifurcation near wall (99.0%), left internal far wall (98.1%), right internal far wall (98.3%), left internal near wall (92.9%), and right internal near wall (88.6%). Some investigators have expressed concern that missing data might bias the estimate of IMT progression rates. 38 However, it is evident that only a small proportion of the information is missing. Furthermore, statistical methods are in use to minimize the missing data issue (missing at random) by using maximum likelihood techniques. 38 Moreover, since progression rates of various walls and sites of the carotid tree are correlated with one another, 37 inclusion of several sites improves power as well as representativeness.
Investigators have also discussed the relative strengths and weaknesses of using information from the far wall alone as opposed to that from both the near and far walls. Although validity of near-wall measurements may be questioned, associations that near-wall IMT has with prevalent and incident cardiovascular disease are similar to those for the far wall. 21, 37 As noted above, if appropriate statistical methods are used, the greater information provided by measurement across more sites should provide greater statistical power and effi ciency. 38 Individual sonographer characteristics have potential to introduce signifi cant variability into ultrasound readings, and to reduce this, investigators have used a standard template to defi ne angles of ultrasound interrogation (Meijer's arc 21 ) ( Fig. 83.2 ). Sonographer variability can also be reduced in multicenter studies by utilizing centralized sonography suites that accommodate patients from several surrounding clinical sites. 39 Reader variability can also be substantial, and for longitudinal studies this can be reduced by (1) reading all studies from a protocol by a single reader toward the end of the protocol to avoid "reader drift"; (2) automated image quantifi cation; (3) training and retraining of readers as well as sonographers (sonographers and readers in our research projects submit 25 practice scans or readings that are reviewed and critiqued prior to receiving initial certifi cation); (4) implementing an ongoing quality control program for both instrumentation and personnel; and (5) central reading sites for multicenter trials. The need for rapid recruitment of large samples for epidemiologic studies and clinical trials with ultrasound outcome has in some cases necessitated development of an international team effort, and the protocols outlined above represent approaches implemented to overcome the substantial challenges encountered. 39, 40 External carotid Internal carotid With implementation of these quality control measures, the quantifi cation of IMTs in the carotid system is highly reproducible. This may partly refl ect the chronic stable nature of this manifestation of arterial disease: IMT is unlikely to be affected by transient metabolic changes. Table  83 .1 presents a portion of the reliability data obtained during the conduct of the Asymptomatic Carotid Artery Plaque Study (ACAPS). 41 Duplicate examinations, usually obtained within 1 month, were conducted on every participant at baseline and at the end of 3 years of follow-up. The average difference in the mean maximum IMT between the two baseline examinations was 0.01 mm, and the standard deviation of this difference was 0.14 mm. These statistics were identical at the end of the trial. Using the standard deviation as a measure of variability, the within-and between-sonographer variabilities at baseline were comparable and low. Although the within-reader variability is one-half the between-reader variability (0.07 and 0.15 mm, respectively), both are fully acceptable.
Validity
The in vitro and in vivo experiments of Pignoli et al. 42 focused on the aorta and common carotid arteries and indicated that IMT values obtained from B-mode imaging did not differ signifi cantly from the IMT as measured on pathologic examination. Wong et al. 43 performed similar measurements on carotid and femoral arteries and concluded that B-mode imaging of IMT on the far (deeper) wall did not provide signifi cantly different results from those obtained by histology. Gamble et al. 44 described in vitro and in situ experiments in the common carotid arteries of cadavers. These indicated that B-mode imaging of the artery wall correlated best with the combined intimal-medial-adventitial thickness as measured from histologic sections, but that increased wall thickness due to intimal atherosclerotic thickening still correlated well with the thickness obtained from B-mode images. Thickness measurements from the far (deeper) wall of a vessel are more clearly defi ned and valid than those from the near (shallower) wall, due to the basic physical principles used in constructing B-mode images. 43 
Normal and Abnormal Intimal-Medial Thicknesses
Data on the distribution of IMTs from the Atherosclerosis Risk in Communities (ARIC) study, a probability sample of middle-aged men and women in four communities in the United States, have been reported. 45 A portion of these data are presented in Table 83 .2, which shows that the median IMT increases with age, is higher in men than in women, and is higher in the bifurcation than in the common and internal carotid arteries. A normal thickness may be represented by the median values of participants in their mid-40s (i.e., in the common carotid artery-0.60 mm for men and 0.54 mm for women). B-mode images of three common carotid artery far-wall segments with increasing IMTs are shown in Figure 83 .3. Part A illustrates an IMT in the upper range of normal; part B shows an IMT slightly less than twice normal; part C shows a protruding plaque with a maximum thickness that is four times normal. Some investigators have advocated use of plaque rather than IMT as a primary index of disease since some increase in IMT may result from hyperplasia rather than atherosclerosis per se. 46 In theory, this approach has merit; however, in practice different investigators have proposed different defi nitions of plaque; most characterize plaque as a lesion whose IMT is 50% greater than a normal appearing nearby segment, 47 48 Investigators who prefer the use of IMT argue that information about plaque is captured through IMT since the maximum IMT is generally measured at the site of a plaque. Furthermore, plaque does not appear to add information about associations with risk factors or with prevalent or incident disease that is not available from measurement of IMT alone.
Characterization of plaque composition from B-mode images has also been advocated by some investigators, 49 because of the well-described association of unstable plaque with acute events 50 ; however, such characterization is complex and diffi cult. The methods described above for assessing IMT evolved from validation studies on normal or near-normal arteries in which the lumen-intima and mediaadventitia boundaries were clearly defi ned. When complex plaques are present, these boundaries may become less well defi ned and other boundaries may develop within the wall that can change the fundamental principles underlying the IMT measurement process and decrease the reproducibility. Current investigations are underway to explore further the potential of ultrasonic B-mode imaging in the characterization of atherosclerotic plaque.
Associations of Cardiovascular Disease Risk Factors with Intimal-Medial Thickness
Since IMT is an index of chronic stable disease, associations with risk factors represent lifetime (more than current) exposure. Data from the Framingham study support this concept. 9 Well-recognized risk factors for clinical manifestations of coronary artery disease include age, male gender, menopausal status, cigarette smoking, diabetes, hypertension, elevated low-density lipoprotein (LDL) cholesterol, and depressed high-density lipoprotein (HDL) cholesterol, and all of these have been shown to be related to increased IMT of the extracranial carotid arteries. [6] [7] [8] [9] [10] [11] [12] [13] 47, [51] [52] [53] In addition, a number of risk factors of putative but hitherto unproven importance for clinical events have been associated with increased IMT. These include passive smoking, 54 
Progression of Intimal-Medial Thickness
Several epidemiologic investigations have quantifi ed IMT progression rates. Although this approach provides a more valid estimate of the impact of risk factors on atherosclerosis, it also represents a greater technologic challenge because IMT changes slowly. Data from a large population-based epidemiologic study in Finland fi rst showed several cardiovascular disease risk factors to be related to IMT progression: age, LDL cholesterol, pack-years of smoking, white blood cell count, and platelet aggregability. 75 In the Atherosclerosis Risk in Communities Study, Chambless et al. 76 identifi ed diabetes, smoking, low HDL cholesterol, pulse pressure, low white blood cell count, and fi brinogen as risk factors for progression. They also found statistically signifi cant associations between the change in IMT along with the change in LDL cholesterol and triglycerides and the onset of diabetes and hypertension. The average annual change in mean common carotid IMT in this study for black women, black men, white women, and white men was 8.4, 7.4, 9.1, and 8.6 μm, respectively. Other population-based studies [77] [78] [79] [80] generally agree that traditional risk factors for cardiovascular events are related to IMT progression, and that progression in healthy individuals is approximately 10 μm per year. Wagenknecht et al. 81 found progression rates of about 8 and 36 μm/year in the common and internal carotid, respectively, in patients with type 2 diabetes mellitus, compared to rates of 4 and 17 μm/year in normal individuals or those with impaired glucose tolerance.
In addition to traditional risk factors, other investigators have associated several factors with more rapid progression of atherosclerosis, including passive smoking, 82 factors related to thrombosis and thrombolysis, [75] [76] [77] hs-C reactive protein, 83 HIV infection, 84 psychosocial stress, 85 and abdominal obesity. 86 Cardiorespiratory fi tness, 87 dietary fi ber intake, 88 and exercise 89 have been associated with slower IMT progression. Estrogen use is associated with plaque but not with IMT progression. 90 Patients with coronary artery disease (CAD) have also been shown to progress their IMT more rapidly than patients free of CAD. 91 In this study of patients with coronary status defi ned at coronary angiography, patients with no CAD had progression rates of about 10 μm/year for the common, bifurcation, and internal carotid arteries, and patients with CAD had progression rates of about 30 μm/year in these segments while the impact of risk factors on progression was greater in patients with CAD than in those free of CAD.
Infl uences of Risk Factor Interventions on Progression of Intimal-Medial Thickness in Clinical Trials
The Food and Drug Administration has long accepted effects of pharmacologic intervention on rate of progression of coronary stenosis as a marker for demonstration of clinical benefi t. More recently, the FDA has similarly accepted change in progression of IMT measured by B-mode ultrasound. 92 Accordingly, many clinical trials have evaluated the effects of various interventions on this outcome. The fi rst of these were studies of lipid-lowering regimens, and 12 of these have been reported to date and are reviewed in Table  83 .3. [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] These trials have consistently shown that cholesterol lowering retards the rate of progression or is associated with net regression of atherosclerosis. In two of these trials 98,104 more aggressive lipid lowering was associated with more dramatic reduction of atherosclerosis progression. Typically, it takes 1 to 3 years to show differences in rates of progression of IMT between intervention and placebo groups or between different interventions. Low-density lipoprotein apheresis has also been associated with retardation of progression of carotid atherosclerosis. 105 In addition, 10 clinical trials have evaluated the effects of antihypertensive therapy on extracranial carotid IMT progression compared to diuretic or placebo. Three of these have been comparisons with angiotensin-converting enzyme (ACE) inhibitors, [106] [107] [108] four have been comparisons with calcium channel blockers, [109] [110] [111] [112] two have been comparisons with beta-blockers, 102, 113 and one was a comparison with an alpha-blocker. 114 One study has compared effects of a calcium channel blocker against a beta-blocker. 115 In general, these trials have shown that antihypertensive treatment slows progression compared to placebo or diuretic, although there have been a few exceptions. To the extent that acute increases or decreases in arterial lumen diameter associated with antihypertensive treatment may artifactually acutely decrease or increase IMT because of the distensibility of the arterial wall, these studies may be subject to criticism. For instance, in the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) study, 109 administration of diuretic was associated with an acute decrease in the carotid lumen diameter (which would be anticipated to acutely increase the IMT), whereas administration of the calcium channel blocker had the opposite (physiologic) effect. The consistency of the results of the various clinical trials is reassuring, however. Diabetes management has been shown to retard progression of IMT in several studies in type 1 diabetes 116 as well as type 2 diabetes (Table 83 .4). [117] [118] [119] Three studies have found no effect of hormone replacement on IMT progression in clinical trials, [120] [121] [122] whereas Hodis et al. 123 did fi nd such an effect. Lifestyle intervention with weight loss, exercise, and stress reduction [124] [125] [126] [127] has been shown to improve progression of IMT, but treatment with omega-3 fatty acids does not. 128 Two of three studies evaluating the effects of antioxidant vitamins or B complex intervention have shown a benefi cial effect on IMT. [129] [130] [131] Treatment with aspirin 132 and other antiplatelet agents 133 has also been shown to have a benefi cial effect.
Associations of Intimal-Medial Thickness with Symptomatic Vascular Disease
Extracranial carotid atherosclerosis has been independently associated with prevalent coronary artery 10, [22] [23] [24] 134, 135 and cerebrovascular 10, 23, 24 disease. The odds ratios for prevalent symptomatic coronary artery and cerebrovascular disease in the Cardiovascular Health Study were 2.84 and 2.56, respectively, when comparing the highest with the lowest quartile of internal carotid IMT. 24 Of interest, increased IMT has also been associated with cerebral white matter lesions, 136, 137 which have themselves been associated with neurologic abnormalities. 138 Increased IMT as identifi ed by B-mode ultrasound of the extracranial carotid arteries is also a predictor of incident coronary events 14, [26] [27] [28] [29] [139] [140] [141] and stroke 26, 28, 30, 31, 140 or the combined end point 26, 140 as well as incident white matter lesions. 142 In an earlier publication from the ARIC study, 139 23% of incident coronary heart disease (CHD) events were found in the population with IMT of ≥1 mm (top 7% of population), and CHD event rates were 1.2% per year for women and 1.3% per year for men in this high IMT subset. By contrast, CHD event rates for the entire population were 0.2% per year for women and 0.7% per year for men. In the most up-to-date analyses from the ARIC study, 20 addition of IMT together with several other nontraditional risk markers to a roster of traditional risk factors improved the area under the receiver operating curve for incident coronary heart disease in men but not women (and IMT was also important when not combined with other nontraditional risk factors). In the Cardiovascular Health Study, IMT was also independently related to incident coronary events. As might be expected, IMT is related to incident stroke. In ARIC, addition of IMT to a basic model including traditional risk factors increased the area under the receiver operating characteristic (ROC) curve for stroke, but this was only statistically signifi cant when combined with a marker of peripheral vascular disease. 31 In the Cardiovascular Health Study, 30 14% of incident strokes in an older population occurred in the 6% of the population with the greatest carotid stenosis (>50%), and hypoechoic plaque (of an ultrasound density comparable to or less than that of the vessel lumen, and perhaps indicative of vulnerable plaque) conferred additional risk. 143 A more recent report from the Cardiovascular Health Study identifi es IMT as an independent risk marker for incident symptomatic cardiovascular events that was at least as strong as the associations seen with traditional risk factors (Fig. 83.4) . 26 In the Rotterdam Study investigators found an ROC area for incident myocardial infarction and stroke of 0.72 when age, sex, prior cardiovascular disease, and traditional risk factors were included, correctly predicting 17% of all subjects with incident disease. Addition of IMT increased the ROC area to 0.75. When only the IMT was used the ROC was 0.71 and 14% of all subjects were correctly predicted; thus, a single carotid IMT measurement was of roughly the same importance as a battery of traditional risk factors in the prediction of cardiovascular disease (CVD) outcomes. 140 Finally, a report has presented evidence for an independent association of IMT with all-cause mortality. 32 Because IMT represents a chronic stable index of disease, changes in lifestyle or pharmacologic modifi cation that might alter the risk of incident disease over weeks or months (e.g., lipid lowering) would not be rapidly refl ected in changes in IMT, and progression of IMT might better predict incident symptomatic vascular disease outcome. In this regard, it has been reported that progression of extracranial carotid atherosclerosis is a stronger risk factor for incident coronary events than baseline coronary stenosis or progression of coronary stenosis. 27 This observation has not been replicated, perhaps because of the challenge inherent in quantifi cation of IMT progression.
Use of B-mode Ultrasound to Defi ne Arterial Dimensions
In addition to IMT, B-mode ultrasound is capable of defi ning arterial dimensions (lumen diameter and interadventitial diameter). Associations of risk factors with arterial dimensions are disconnected from associations with atherosclerosis in the common carotid artery such that increased IMT of the common carotid is associated with increased rather than decreased lumen diameter, 144 and most risk factors that are associated with increased IMT (aging, male gender, cigarette smoking, hypertension, diabetes) are also associated with increased common carotid lumen diameter (LDL cholesterol is the exception and is associated with smaller arterial lumina in the common carotid artery). [145] [146] [147] This apparent paradox is consistent with remodeling of the artery due to atherosclerosis and is reminiscent of compensatory dilation observed in the coronary arteries. 2 These observations have recently been extended to compare patients with and without defi ned coronary artery disease; although associations of lumina and IMT are similar between coronary cases and controls in the common carotid, there is a suggestion of a greater tendency to lumen compromise with increasing IMT in the internal carotid for patients with CAD compared to CAD-free controls.
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Associations of Hereditary and Genetic Factors with Intimal-Medial Thickness
The use of IMT to evaluate the infl uence of heredity and genetic variables on atherosclerosis is appealing. As described above, the noninvasive nature of this technology makes it ideal for use in large asymptomatic populations, and its reliability and validity, both as a faithful representation of underlying tissue and as a marker for increased vascular risk, provide a unique opportunity to test associations. Investigators can magnify power by focusing on a more proximate intermediate phenotype (atherosclerosis), while discordance between atherosclerosis and clinical events can also be evaluated. Duggirala et al. 149 were among the fi rst to investigate heritability of IMT in 46 sibships in Mexico City and estimated heritability of 86% to 92% for internal carotid atherosclerosis. Xiang et al. 150 also found high heritability estimates of 72% for the common carotid. Subsequently, heritability estimates of from 21%-67% have been derived by various groups. 150 Manolio et al.'s 34 report includes a table that delineates the associations of various carotid artery phenotypes in nine studies reported through 2003. [149] [150] [151] [152] [153] [154] [155] [156] [157] A number of genetic variants have also been studied for their relation to carotid phenotypes, including variants associated with angiotensin-I-converting enzyme, apolipoprotein E, angiotensinogen and angiotensin II type 1 receptor, methylene tetrahydrofolate reductase, paraoxonase, nitric oxide synthase, various genes related to lipid and lipoprotein levels (e.g., hepatic lipase), and genetic variants related to hemostatic and infl ammatory factors, interleukins and immune response, platelet receptors, and oxidative pathways. [33] [34] [35] Of all the variants studied, the 6A allele of the matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism has been associated with higher IMT and stenosis in all studies examining it. 158 Other markers are under active investigation in this exciting new approach to quantifi cation of the genetics of atherosclerosis.
Summary
B-mode ultrasound has clearly become a mature technology for quantifi cation and monitoring of the extent and progression of IMT of the extracranial carotid arteries. Use of this technology has provided hitherto unimagined new insights about risk factors for arterial disease and relations of asymptomatic arterial disease to symptomatic illness, as well as relations of underlying atherosclerosis to incident coronary heart disease and stroke. It is now an accepted marker for atherosclerosis, and numerous pharmaceutical studies have accordingly tested effects of pharmacologic intervention to retard carotid IMT progression. Evaluation of hereditary and genetic factors related to underlying atherosclerosis in asymptomatic samples represents an entirely new line of promising investigation. The simple, harmless nature of this investigation has led to an explosion of information surrounding its use; whereas in 1983, before establishment of the reliability and validity of B mode for quantifi cation of subclinical disease, only approximately 70 articles addressed the use of B mode in the carotid arteries, the year 2003 saw more than 500 such contributions. Adoption of this technology truly represents a paradigm shift in investigation of atherosclerosis. Nonetheless, several questions about the use of B mode to quantify atherosclerosis remain, including the utility of characterization of plaque as opposed to IMT and of quantifi cation of plaque characteristics. Since IMT and plaque identify structural aspects of arterial disease that may carry fundamentally different information regarding risk, this distinction may be important. Questions also remain about the use of measurements of carotid IMT from one segment (the far wall of the common carotid artery) as opposed to multiple segments. Finally, use of this technology in clinical trials of agents that may acutely increase or decrease arterial lumen diameter may also be somewhat problematic.
The potential for B-mode ultrasound to identify individuals who stand to benefi t most from lifestyle modifi cation or pharmacologic intervention has not yet been fully realized. Extreme thickening of the intima-media complex identifi es a small subgroup of individuals whose risk of incident cardiac and cerebrovascular events is two-to fi vefold greater than that of the parent population. In the older population of the cardiovascular health study (CHS) the relationship of IMT to cardiovascular outcome was independent and as strong as that of traditional risk factors, and IMT by itself was as powerful a predictor of cardiovascular events as the traditional risk factors. 20 The Rotterdam investigators also showed that IMT had approximately the same predictive power for future events as a group of traditional risk factors. 140 However, although IMT appears to be a particularly powerful tool for prediction of incident events, its clinical use would inevitably be incorporated into a risk stratifi cation scheme that included the traditional risk factors (age, gender, blood pressure, diabetes, smoking behavior, lipid profi le, menopausal status). In this setting, the somewhat marginal improvement in predictive power provided by the technique likely would not justify the considerable effort involved in quality control of laboratories that might carry out assessments for routine clinical purposes. Furthermore, the underlying risk of cardiovascular events for otherwise healthy middle-aged populations is so low (about 0.5% per year for cardiac events 20 ) that even those individuals with extreme thickening of the intima-media complex have a low risk rate, and, in absolute terms, the majority of events occurs in the population with normal or only modestly increased IMT. Since risk factors might be less tightly linked to symptomatic disease in an elderly population, the addition of IMT measurements to risk equations might help identify asymptomatic elderly individuals at increased risk of cardiovascular disease, 26 but this awaits further investigation. Changes in IMT occur slowly and error in measurement of change is greater than error in measurement of cross-sectional IMT. This compromises the potential clinical use of measurement of change in IMT for prediction of cardiovascular outcome, and perhaps explains why the provocative results of Hodis et al. 27 have not been replicated.
Conversely, the stability of IMT makes it an ideal marker for response of the arterial wall to long-term risk factor exposure. Also, IMT is ideally suited for identifi cation of risk factors, and several new risk factors (including gene polymorphisms) have been identifi ed using this method. Furthermore, it is an excellent indicator of long-term effects of risk factor change in clinical trials. It is likely that quantifi cation of arterial structure in conjunction with risk factor measurements or other indices of vascular disease (e.g., indices of vascular function) that change more rapidly with behavior modifi cation or pharmacologic intervention will allow investigators and clinicians to better predict individual risk in the future.
